Satralizumab in Aneurysmal Subarachnoid Hemorrhage
Conditions: Aneurysmal Subarachnoid Hemorrhage; Delayed Cerebral Ischemia Intervention: Drug: Satralizumab Sponsors: University of Florida; Genentech, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Research | Subarachnoid Hemorrhage